Hepatitis C Medicine Manufacturer

Aprazer Healthcare: The Leaders in Hepatitis C Care

Innovative solutions, manufacturing, supplying, and exporting the widest range of Hepatitis C medicines.

Hepatitis C is widely curable when treated timely. With a motive to cure Hepatitis C worldwide, we offer an extensive range of affordable solutions.

The State-of-the-Art Manufacturing Capabilities:

Equipped with cutting-edge technology, WHO-GMP approved facilities with periodical audits for quality systems, practices, and documentation.

With a focus on research and development, we explore new treatments, developing patient-centric drugs and next-generation antivirals to offer effective care and safe therapeutics.

The Company’s Leading Drug Candidates:

Velakast (Sofosbuvir 400 mg + Velpatasavir 100 mg) –
Offers pan-genotypic coverage, treats all types of HCV genotype.

Sofokast Plus (Daclatasvir and Sofosbuvir) –
A pan-genotype combination, effective against all types of HCV virus, with strong antiviral effect.

Ledikast (Ledipasvir & Sofosbuvir) –
A fixed-dose combination to treat the most resistant genotype 1 with 95% cure rates.

The Trusted Partners in Pharmaceutical Manufacturing, Export, and Supply:

• Continuous manufacturing: optimized production with continuous processes, reducing manufacturing cost and minimizing wastage.
• Agile processes: flexibly adapting to changing patient needs and latest innovations.
• Scalability: scaled production capacities to meet the demand for Hepatitis C medicines.

With a Vision Towards a Hepatitis C-Free Future

We collaborate with:
• Global Health Agencies
• Hospitals
• Healthcare Institutions
• Healthcare Professionals